The charges would appear serious – the FDA says the drugmakers variously omitted
material facts; miminized important risks; overstated efficacy or made
unsubstantiated claims. …
Year: 2008
The Genius Scientist Who Improved Your Life That You Never Heard of
Nikola Tesla stands as a poster boy for inventors, scientists, doctors and
educators of all kinds whose ideas and life’s work is dismissed because it is
found to be too beneficial to mankind, and not lucrative enough for big
business. …
NEWS: Padlock probes and RCA-LAMP light the way to rapid DNA detection
The resulting isothermal RCA-LAMP reaction increases speed significantly over
the comparable hyperbranching method and improves convenience for field
applications where thermal cycling may be difficult. …
Rules on Bioengineered Animals: FDA to Release Guidelines for Stages of Genetic Modification
“I don’t think what’s being announced will protect humans and the environment from all the potential risks that a genetically engineered animal may pose,” said Jaffe of the Center for Science in the Public Interest [and he’s avidly pro-GM!]
GSK gets bad press in U.S., Argentina
Families in Argentina are saying GlaxoSmithKline tricked them into participating
in an experimental vaccine trial by telling them their children were receiving
medical treatment …
Investigators: Most data on drugs never available
“Regardless of the cause, publication bias harms the public good by impairing
the ability of clinicians and patients to make informed clinical decisions, and
the ability of scientists to design safer and more efficient trials based on
past findings,” the authors wrote. “Publication bias can thus be considered a
form of scientific misconduct.” …
Study: Data doesn’t support women’s Lipitor use
“Our findings indicate that each year, reasonably healthy women spend billions
of dollars on drugs in the hope of preventing heart attacks, but that scientific
evidence supporting their hope does not exist,” …
Top 10 mistakes biotechs make (and how to avoid them)
“When the FDA says ‘we think you ought to consider’ something, that should not
be viewed as a suggestion, but as a mandate,” he explains. “Companies are
foolish if they don’t follow what the FDA has suggested.” A biotech takes on
significant and unnecessary risk if it doesn’t follow an FDA suggestion or
proactively address the FDA’s concerns. …
Biotech animals focus of regulatory review
While genetic engineering is common in the food industry, a number of biotechs
are also using the science to produce hormones and antibodies that can be used
therapeutically. …
WEBWATCH: Crop cop
Fortunately, AGBIOS, a Canadian company with vast experience in public safety
and risk assessment of biotechnology products, has taken upon itself to deliver
an online repository of knowledge about these important organisms. …
AƦČ章Ɛ䁈Ɛ